BioCellgraft Inc. pursues its development towards the unquestionable leadership position on the untapped business field of oral soft tissue management and its benefits on youthful aesthetic and well-being.
Striving for this leading position in oral health care, BioCellgraft Inc. spent the last months by attracting major clinicians in US and Europe to evaluate the display and the usability of its products extracted from the human placenta (HCTM: Human Connective Tissue Matrix) materials in real life applications.
Taking into consideration potential clinical performances, these highly regarded clinical peers came to a consensus on the following clinical indications suitable to be treated by the injectable form of HCTM.
- Gingival thin biotype (enhancement towards thick biotype)
- Gingival recession and enlargement
- Interdental papilla loss or volume reduction (black triangle)
- Alveolar ridge preservation (alveolar socket management)
- by bioactivation of bone grafting material
- Iatrogenic or deficient gingiva conditions following soft tissue impairment.
- Gingival sealing around dental implants (in case of peri-implantitis treatment)
Two groups of clinicians were selected, one in Europe and one in the US which shall generate and collect clinical data on alveolar ridge preservation and paying special attention to soft tissue impairment in case of deficient or delayed healing process.
Using HCTM gel, the above indications can presumably be treated by minimally invasive surgical procedures. This enlarges the number of benefiting patients and holds promises in the overall advancement of oral healthcare.
On a pure business perspective BioCellgraft Inc. was approached by two large medical devices distributors which wish to secure for themselves respectively the US and the European market of oral soft tissue management.
The BioCellgraft Inc. Executive and Management teams still believe in the “maverick” experience, we analyse and understand situations swiftly, we think “out of the box”, we take decision and execute promptly!
